Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Phillips

Showing results (261-270 of 273) with videos related to

Pageof 28
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 1, 1993
Lipid peroxidation does not appear to be a factor in late radiation injury of the cervical spinal cord of ratsP H Gutin, K J Levin, M W McDermott, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1991
External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2P H Gutin, M D Prados, T L Phillips, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: the UCSF experienceM D Prados, P H Gutin, T L Phillips, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu, T F Pajak, A Trotti, et al.
Neurosurgery|May 1, 1995
Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boostP K Sneed, M D Prados, M W McDermott, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1996
Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiformeP K Sneed, K R Lamborn, D A Larson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 1998
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytomaM D Prados, C B Scott, M Rotman, et al.
The Cancer Journal From Scientific American|April 9, 1998
Gamma knife radiosurgery for malignant melanoma brain metastasesS K Seung, P K Sneed, M W McDermott, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiformeM D Prados, W M Wara, P K Sneed, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1982
Treatment of cancer with heavy charged particlesJ R Castro, W M Saunders, C A Tobias, et al.
Pageof 28

Showing results (261-270 of 273) with videos related to

Sort By:
Pageof 28
International Journal of Radiation Oncology, Biology, Physics|January 1, 1993
Lipid peroxidation does not appear to be a factor in late radiation injury of the cervical spinal cord of ratsP H Gutin, K J Levin, M W McDermott, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1991
External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2P H Gutin, M D Prados, T L Phillips, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: the UCSF experienceM D Prados, P H Gutin, T L Phillips, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu, T F Pajak, A Trotti, et al.
Neurosurgery|May 1, 1995
Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boostP K Sneed, M D Prados, M W McDermott, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1996
Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiformeP K Sneed, K R Lamborn, D A Larson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 1998
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytomaM D Prados, C B Scott, M Rotman, et al.
The Cancer Journal From Scientific American|April 9, 1998
Gamma knife radiosurgery for malignant melanoma brain metastasesS K Seung, P K Sneed, M W McDermott, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiformeM D Prados, W M Wara, P K Sneed, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1982
Treatment of cancer with heavy charged particlesJ R Castro, W M Saunders, C A Tobias, et al.
Pageof 28